** ASX-listed shares of AVITA Medical Inc AVH.AX fall as
much as 16.2% to A$3.770, their lowest since Jan 8
** Stock set for worst day since Oct 3, if losses hold
** Co expects March-qtr commercial revenue between $11 mln
and $11.3 mln, lower than previous forecast of $14.8 mln to
$15.6 mln
** Says the downward revision due to slower-than-expected
conversion rate of new accounts for expanded label of
full-thickness skin defects
** AVH top loser on ASX All Ordinaries index .AORD
** As of last close, stock up 4.9% this year
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))